| Pharmaceutical active ingredients: |
| ClioquinolHydrocortisone Acetate |
| Available forms, composition and doses of Barquinol HC: |
| N / A |
| Barquinol HC medical category: |
| Human:Anti-inflammatory agentsMiscellaneous antifungals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07CA01 - Hydrocortisone and antibioticsP01AA52 - Clioquinol, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vioform Hydrocortisone | Clioquinol; Hydrocortisone | Novartis; Paladin Laboratories; Sigma Pharmaceuticals; Squire Pharmaceuticals |
| Vioform Hydrocortisone Mild | Clioquinol; Hydrocortisone | Novartis |
| Vioformio Hidrocortisona | Clioquinol; Hydrocortisone | Novartis |
| Vioformo-Cort | Clioquinol; Hydrocortisone | Novartis |
| Antiblef Eczem | Clioquinol; Hydrocortisone Acetate | Novartis |
| Cortoquinol | Clioquinol; Hydrocortisone Acetate | East India Pharmaceutical Works |
| Hydroderm-C | Clioquinol; Hydrocortisone Acetate | Integrated Contract Manufacturing |
| 1 + 1 F | Clioquinol; Hydrocortisone; Pramoxine Hydrochloride | Dunhall Pharmaceuticals |
| Ictioformica | Clioquinol; Ichthammol; Triamcinolone Acetonide | Alcon |
| Suyodil | Clioquinol; Kaolin; Pectin | Farmacos Continentales |